News

Filter

1 to 9 of 100 results

Study finds HRT increases the risk of ovarian cancer

16-02-2015

Research by the University of Oxford, published in the prestigious medical magazine The Lancet, found…

PharmaceuticalResearchWomen's Health

Ligand out-licenses lasofoxifene to Sermonix

03-02-2015

USA-based drugmaker Ligand Pharmaceuticals has signed a license agreement with privately-held Sermonix…

Anti-Arthritics/RheumaticsFablynlasofoxifeneLicensingLigand PharmaceuticalsPharmaceuticalSermonix PharmaceuticalsUSAWomen's Health

Gedeon Richter enters license and distribution deal with Bayer

Gedeon Richter enters license and distribution deal with Bayer

27-01-2015

Hungary’s largest drugmaker Gedeon Richter says that it has entered into a license and distribution…

BayerEuropeGedeon RichterLicensingLisvyMarkets & MarketingPharmaceuticalReproductiveSouth AmericaWomen's Health

Ph III trial for AbbVie’s elagolix meets endpoints

08-01-2015

US pharma major AbbVie and partner Neurocrine Biosciences have announced positive top-line results from…

AbbVieelagolixNeurocrine BiosciencesPharmaceuticalResearchWomen's Health

Columbia Labs appoints Bridget Martell to newly-created chief medical officer position

Columbia Labs appoints Bridget Martell to newly-created chief medical officer position

06-01-2015

Women’s health specialist Columbia Laboratories has appointed Bridget Martell to the newly-created…

BoardroomBridget MartellCOL-1077Columbia LaboratoriesPharmaceuticalWomen's Health

Milestone from Gedeon Richter as Palatin initiates Ph III bremelanotide study

Milestone from Gedeon Richter as Palatin initiates Ph III bremelanotide study

31-12-2014

US biopharma company Palatin Technologies says it has started its bremelanotide pivotal registration…

bremelanotideGedeon RichterLicensingPalatin TechnologiesPharmaceuticalResearchWomen's Health

Roche enters NIPT sector with acquisition of Ariosa Diagnostics

Roche enters NIPT sector with acquisition of Ariosa Diagnostics

03-12-2014

Swiss pharma major Roche has acquired Ariosa Diagnostics, a privately-held company based in San Jose,…

Ariosa DiagnosticsMergers & AcquisitionsPharmaceuticalRocheUSAWomen's Health

Afaxys announces wider US availability of ella emergency contraceptive

12-11-2014

US drugmaker Afaxys Pharmaceuticals, a division of Afaxys Inc, has announced wider US availability of…

AfaxysellaHRA PharmaMarkets & MarketingPharmaceuticalReproductiveUSAWomen's Health

1 to 9 of 100 results

Back to top